Dissociation of cerebrospinal fluid amyloid- and tau levels in patients with prolonged posttraumatic disorders of consciousness

被引:9
|
作者
Bagnato, Sergio [1 ,2 ]
Andriolo, Maria [3 ]
Boccagni, Cristina [1 ,2 ]
Sant'Angelo, Antonino [1 ,2 ]
D'Ippolito, Maria Enza [3 ]
Galardi, Giuseppe [1 ,2 ]
机构
[1] Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[2] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[3] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy
关键词
Amyloid beta; traumatic brain injury; total tau; phosphorylated tau; vegetative state; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; RISK; BIOMARKERS; INFLAMMATION; CONCORDANCE; POPULATION; PATHOLOGY;
D O I
10.1080/02699052.2018.1479042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease (AD). Although the mechanisms that lead to AD after a TBI are unclear, we hypothesize that changes in amyloid- (A) metabolism and abnormal tau phosphorylation are reasonable candidates.Objective: To investigate A and tau dynamics in the chronic phase of TBI.Methods: We evaluated A(1-42), total tau (t-tau), and phosphorylated tau (p-tau) levels in the cerebrospinal fluid (CSF) of 15 patients who developed a prolonged disorder of consciousness after a severe TBI (mean time from TBI 271.6176.5days).Results: Reduced A(1-42) levels (median 258pg/ml, range 90-833.6) were observed in 14/15 patients (93.3%) with severe post-TBI disorders of consciousness. These CSF analysis data did not correlate with time since TBI or with the patients' level of consciousness as determined by the Coma Recovery Scale Revised. Normal t-tau levels (median 95.2 pg/ml, range 52-256.9) were found in all patients. Normal p-tau levels (median 22.2pg/ml, range 14-72) were observed in 14/15 patients, with just a single patient having a slightly increased p-tau level.Conclusion: The present findings show that A and tau are differently affected in the chronic phase of severe TBI.
引用
收藏
页码:1056 / 1060
页数:5
相关论文
共 50 条
  • [21] A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
    Katherine W. Turk
    Alexandra Geada
    Victor E. Alvarez
    Weiming Xia
    Jonathan D. Cherry
    Raymond Nicks
    Gaoyuan Meng
    Sarah Daley
    Yorghos Tripodis
    Bertrand R. Huber
    Andrew E. Budson
    Brigid Dwyer
    Neil W. Kowall
    Robert C. Cantu
    Lee E. Goldstein
    Douglas I. Katz
    Robert A. Stern
    Michael L. Alosco
    Jesse Mez
    Ann C. McKee
    Thor D. Stein
    Alzheimer's Research & Therapy, 14
  • [22] Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment
    Malpas, Charles B.
    Saling, Michael M.
    Velakoulis, Dennis
    Desmond, Patricia
    O'Brien, Terence J.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (04) : 965 - 975
  • [23] Amyloid-β Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
    Santos, Alexander Navarrete
    Ewers, Michael
    Minthon, Lennart
    Simm, Andreas
    Silber, Rolf-Edgar
    Blennow, Kaj
    Prvulovic, David
    Hansson, Oskar
    Hampel, Harald
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (01) : 171 - 176
  • [24] Low cerebrospinal fluid Amyloid-βeta 1-42 in patients with tuberculous meningitis
    Stroffolini, Giacomo
    Guastamacchia, Giulia
    Audagnotto, Sabrina
    Atzori, Cristiana
    Trunfio, Mattia
    Nigra, Marco
    Di Stefano, Alessandro
    Di Perri, Giovanni
    Calcagno, Andrea
    BMC NEUROLOGY, 2021, 21 (01)
  • [25] A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
    Turk, Katherine W.
    Geada, Alexandra
    Alvarez, Victor E.
    Xia, Weiming
    Cherry, Jonathan D.
    Nicks, Raymond
    Meng, Gaoyuan
    Daley, Sarah
    Tripodis, Yorghos
    Huber, Bertrand R.
    Budson, Andrew E.
    Dwyer, Brigid
    Kowall, Neil W.
    Cantu, Robert C.
    Goldstein, Lee E.
    Katz, Douglas I.
    Stern, Robert A.
    Alosco, Michael L.
    Mez, Jesse
    McKee, Ann C.
    Stein, Thor D.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [26] Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease
    Santangelo, Roberto
    Cecchetti, Giordano
    Bernasconi, Maria Paola
    Cardamone, Rosalinda
    Barbieri, Alessandra
    Pinto, Patrizia
    Passerini, Gabriella
    Scomazzoni, Francesco
    Comi, Giancarlo
    Magnani, Giuseppe
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (01) : 183 - 199
  • [27] False Recognition Correlates with Amyloid-β1-42 but not with Total Tau in Cerebrospinal Fluid of Patients with Dementia and Mild Cognitive Impairment
    Hildebrandt, Helmut
    Haldenwanger, Andreas
    Eling, Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (01) : 157 - 165
  • [28] Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration
    Toombs, Jamie
    Foiani, Martha S.
    Paterson, Ross W.
    Heslegrave, Amanda
    Wray, Selina
    Schott, Jonathan M.
    Fox, Nick C.
    Lunn, Michael P.
    Blennow, Kaj
    Zetterberg, Henrik
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 56 (03) : 885 - 891
  • [29] Changes in Cerebrospinal Fluid Tau and β-Amyloid Levels in Diabetic and Prediabetic Patients: A Meta-Analysis
    Lu, Yanhui
    Jiang, Xinjun
    Liu, Shuling
    Li, Mingzi
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [30] Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
    Giacomo Stroffolini
    Giulia Guastamacchia
    Sabrina Audagnotto
    Cristiana Atzori
    Mattia Trunfio
    Marco Nigra
    Alessandro Di Stefano
    Giovanni Di Perri
    Andrea Calcagno
    BMC Neurology, 21